Scarica l'app Stockscreener
3.23
3.00%
-0.10
Dopo l'orario di chiusura:
3.24
0.01
+0.31%
Precedente Chiudi:
$3.33
Aprire:
$3.27
Volume 24 ore:
279.85K
Relative Volume:
1.77
Capitalizzazione di mercato:
$105.52M
Reddito:
$1.82M
Utile/perdita netta:
$-267.63M
Rapporto P/E:
-0.1602
EPS:
-20.1639
Flusso di cassa netto:
$-50.53M
1 W Prestazione:
+27.67%
1M Prestazione:
+64.80%
6M Prestazione:
-33.54%
1 anno Prestazione:
-78.21%
Intervallo 1D:
$3.12
$3.38
Intervallo di 1 settimana:
$2.51
$3.40
Portata 52W:
$1.40
$15.00
Cibus Inc Stock (CBUS) Company Profile
Nome
Cibus Inc
Settore
Industria
Telefono
(858) 450-0008
Indirizzo
6455 NANCY RIDGE DRIVE, SAN DIEGO
Confronta CBUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
3.23 | 82.66M | 1.82M | -267.63M | -50.53M | -20.16 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-29 | Iniziato | Alliance Global Partners | Buy |
| 2024-07-19 | Ripresa | Canaccord Genuity | Buy |
| 2023-10-09 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-19 | Ripresa | Canaccord Genuity | Buy |
Cibus Inc Borsa (CBUS) Ultime notizie
Transcript : Cibus, Inc. Presents at Bank of America Ag Tech Conference 2025, May-20-2025 03 - marketscreener.com
Cibus Stockholders Approve 2025 Employee Stock Plan - TipRanks
Cibus, Inc. Co-Founder Participates in BofA Securities 2025 AgTech Virtual Conference to Discuss Gene Editing Innovations and Pipeline Progression - Nasdaq
Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat - The Manila Times
Cibus Approves Key Measures at Annual Meeting - TipRanks
Cibus at Alliance Global Partners: Strategic Gene Editing Insights - Investing.com
Cibus at Alliance Global Partners: Strategic Gene Editing Insights By Investing.com - Investing.com Nigeria
Cibus director Prante Gerhard sells $2,898 in stock - MSN
Cibus to Participate in Alliance Global Partner's Annual Virtual Healthcare Company Showcase - The Manila Times
Cibus to Participate in Alliance Global Partner's Annual Virtual Healthcare Company Showcase | CBUS Stock News - GuruFocus
Cibus, Inc. to Present Advances in Gene-Editing Technology at AGP Annual Virtual Healthcare Company Showcase - Nasdaq
Cibus to Participate in Alliance Global Partner’s Annual Virtual Healthcare Company Showcase - Bluefield Daily Telegraph
Cibus to Reveal Next-Gen Agricultural Biotech Roadmap and Commercialization Plans at Healthcare Showcase - Stock Titan
Canaccord Genuity Group Lowers Cibus (NASDAQ:CBUS) Price Target to $17.50 - MarketBeat
Cibus, Inc. (NASDAQ:CBUS) Q1 2025 Earnings Call Transcript - MSN
Cibus (NASDAQ:CBUS) Posts Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Barclays PLC Acquires 7,106 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Ecuador Determines Cibus Herbicide Tolerance Rice Traits are Equivalent to Conventional Breeding - ISAAA
Raymond James Financial Inc. Purchases Shares of 32,120 Cibus, Inc. (NASDAQ:CBUS) - Defense World
Granby Capital Management LLC Acquires 150,000 Shares of Cibus, Inc. (NASDAQ:CBUS) - MarketBeat
Cibus (NASDAQ:CBUS) Given New $17.50 Price Target at Canaccord Genuity Group - Defense World
Cibus, Inc. Earnings Call: Achievements and Challenges - MSN
Cibus (CBUS) Maintained at Buy by Canaccord Genuity, Price Targe - GuruFocus
Cibus (CBUS) Maintained at Buy by Canaccord Genuity, Price Target Lowered | CBUS Stock News - GuruFocus
Cibus (CBUS) Target Price Adjusted by Canaccord Analyst Amid Revenue Challenges | CBUS Stock News - GuruFocus
Promising Growth and Market Expansion Drive Buy Rating for Cibus, Inc. - TipRanks
Cibus, Inc. (NASDAQ:CBUS) Shares Bought by Renaissance Technologies LLC - MarketBeat
Cibus Inc (CBUS) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo
Cibus, Inc. Reports Q1 2025 Financial Results and Business Progress - TipRanks
Cibus: Q1 Earnings Snapshot - The Washington Post
Cibus (CBUS) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Earnings call transcript: Cibus Inc Q1 2025 sees rising losses amid innovation push - Investing.com
Cibus Inc Reports Q1 2025 Revenue of $1.034 Million, Missing Analyst Estimate of $1.14 Million - GuruFocus
Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025 - The Manila Times
Ecuador Approves Cibus Herbicide Tolerance Rice Traits As Equivalent to Conventional Breeding - AgriBusiness Global
Cibus announces Ecuador approved Cibus herbicide tolerance Rice traits - TipRanks
Cibus (CBUS) Gains Approval in Ecuador for Herbicide Tolerant Rice | CBUS Stock News - GuruFocus
Ecuador Approves Cibus Herbicide Tolerance Traits as Equivalent to Conventional Breeding - The Manila Times
Cibus (CBUS) to Post Earnings on Thursday - MarketBeat
Cibus Inc expected to post a loss of 66 cents a shareEarnings Preview - TradingView
Renaissance Technologies LLC Buys 114,800 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus director Prante sells $2,875 in stock - MSN
Cibus Inc Azioni (CBUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.89%
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):